Table 3 Phenotype frequencies of HLA-ABDR alleles for severe and mild groups

A1

5 (8.9%)

4 (10.0%)

NS*

A2

16 (28.6%)

6 (15.0%)

NS*

A3

5 (8.9%)

2 (5.0%)

NS*

A11

10 (17.9%)

6 (15.0%)

NS*

A23

0 (0.0%)

3 (7.5%)

0.069

Borderline

A24

12 (21.4%)

11 (27.5%)

NS*

A26

3 (5.4%)

1 (2.5%)

NS*

A29

1 (1.8%)

2 (5.0%)

NS*

A30

2 (3.6%)

3 (7.5%)

NS*

A32

1 (1.8%)

1 (2.5%)

NS*

A33

0 (0.0%)

1 (2.5%)

NS*

A68

1 (1.8%)

0 (0.0%)

NS*

B7

5 (8.9%)

3 (7.5%)

NS*

B8

2 (3.6%)

1 (2.5%)

NS*

B13

2 (3.6%)

1 (2.5%)

NS*

B18

3 (5.4%)

0 (0.0%)

NS*

B27

1 (1.8%)

0 (0.0%)

NS*

B35

17 (30.4%)

13 (32.5)

NS*

B37

1 (1.8%)

1 (2.5%)

NS*

B38

1 (1.8%)

0 (0.0%)

NS*

B39

1 (1.8%)

1 (2.5%)

NS*

B40

1(1.8%)

3 (7.5%)

NS*

B41

1(1.8%)

1 (2.5%)

NS*

B44

4 (7.1%)

0 (0.0%)

NS*

B49

0 (0.0%)

3 (7.5%)

0.069

Borderline

B50

2 (3.6%)

0 (0.0%)

NS*

B51

4 (7.1%)

10 (25.0%)

0.016

Significant

B52

3 (5.4%)

0 (0.0%)

NS*

B54

1 (1.8%)

0 (0.0%)

NS*

B55

5 (8.9%)

0 (0.0%)

0.062

Borderline

B57

2 (3.6%)

2 (5.0%)

NS*

B64

0 (0.0%)

1 (2.5%)

NS*

DR3

4 (7.1%)

2 (5.0%)

NS*

DR4

10 (17.9%)

2 (5.0%)

0.055

Borderline

DR7

5 (8.9%)

3 (7.5%)

NS*

DR10

2 (3.6%)

2 (5.0%)

NS*

DR11

12 (21.4%)

11 (27.5%)

NS*

DR13

4 (7.1%)

7 (17.5%)

NS*

DR14

5 (8.9%)

6 (15.0%)

NS*

DR15

9 (16.1%)

5 (12.5%)

NS*

DR16

5 (8.9%)

2 (5.0%)

NS*